UL Ventures' parent company will offer assistance in growth and compliance to the healthcare risk assessment platform developer, which has just raised series B funding.
KenSci, a US-based provider of risk assessment software for the healthcare industry, has secured $22m in a series B round that included safety equipment producer UL’s corporate venturing unit, UL Ventures.
Investment firm Polaris Partners led the round, which also featured venture capital firms Ignition Partners, Osage University Partners and Mindset Ventures.
Founded in 2015, KenSci has developed a platform that combines healthcare data from clinics, insurance claims and patients with machine learning technology to weigh up the risks of…
